Damona Pharmaceuticals

Damona Pharmaceuticals

Private
TorontoHealthcare & Life Scienceshttps://damonapharma.com

Last Round

Seed

Sep 26, 2022

Total Funding Raised

$5.5M

Company Overview

Damona Pharmaceuticals is a drug discovery and pharmaceuticals company developing therapies designed to restore cognitive function across neurological and psychiatric disorders.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials, Mental Health, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

small molecule therapeuticspositive allosteric modulatorPAMcognitive deficit treatmentcentral nervous system disordersCNS disordersGABA-A receptor modulatorprecision neuromedicineneurotherapeuticspreclinical pharmadrug discoveryclinical trialsmajor depressive disorderMDDAlzheimer's diseasepharma licensingschizophreniabiotech spin-out

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Damona Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Damona Pharmaceuticals Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedSep 26, 2022

Key People

Founding team and executive leadership

John Reilly

Chief Executive Officer

Executive Team

Damona Pharmaceuticals Investors

Notable investors and investment history

Damona Pharmaceuticals Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Damona Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Damona Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range4
Year Founded2019
Last FundingSep 26, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.